Nurix Therapeutics Inc (NRIX) — Long-term Investment Intensity
Nurix Therapeutics Inc (NRIX) has a Long-term Investment Intensity of 1.8% as of August 2024. Long-term investments of $9.47 Million represent 1.8% of total assets of $513.60 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check how aggressively does Nurix Therapeutics Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Nurix Therapeutics Inc Long-term Investment Intensity (2019–2023)
This chart shows how Nurix Therapeutics Inc's Long-term Investment Intensity has evolved across 5 annual periods from 2019 to 2023. As of August 2024, the intensity stands at 1.8%, reflecting long-term investments of $9.47 Million against total assets of $513.60 Million USD. Explore Nurix Therapeutics Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Nurix Therapeutics Inc (2019–2023)
The table below presents the year-by-year Long-term Investment Intensity for Nurix Therapeutics Inc from 2019 to 2023, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Nurix Therapeutics Inc stock valuation.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2023 | 2.1% | $7.42 Million | $355.60 Million | ▼ -13.2 pp |
| 2022 | 15.3% | $63.88 Million | $416.76 Million | ▼ -13.4 pp |
| 2021 | 28.8% | $137.19 Million | $476.77 Million | ▲ +5.8 pp |
| 2020 | 22.9% | $90.89 Million | $396.34 Million | ▲ +21.8 pp |
| 2019 | 1.1% | $506.00K | $44.05 Million | — |